BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18508766)

  • 1. Elongin B/C recruitment regulates substrate binding by CIS.
    Piessevaux J; De Ceuninck L; Catteeuw D; Peelman F; Tavernier J
    J Biol Chem; 2008 Aug; 283(31):21334-46. PubMed ID: 18508766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of the SOCS2-elongin C-elongin B complex defines a prototypical SOCS box ubiquitin ligase.
    Bullock AN; Debreczeni JE; Edwards AM; Sundström M; Knapp S
    Proc Natl Acad Sci U S A; 2006 May; 103(20):7637-42. PubMed ID: 16675548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of cytokine-inducible SH2-containing protein (CIS) by ubiquitination and Elongin B/C interaction.
    Jensik PJ; Arbogast LA
    Mol Cell Endocrinol; 2015 Feb; 401():130-41. PubMed ID: 25448846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation.
    Zhang JG; Farley A; Nicholson SE; Willson TA; Zugaro LM; Simpson RJ; Moritz RL; Cary D; Richardson R; Hausmann G; Kile BT; Kent SB; Alexander WS; Metcalf D; Hilton DJ; Nicola NA; Baca M
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2071-6. PubMed ID: 10051596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The SOCS box domain of SOCS3: structure and interaction with the elonginBC-cullin5 ubiquitin ligase.
    Babon JJ; Sabo JK; Soetopo A; Yao S; Bailey MF; Zhang JG; Nicola NA; Norton RS
    J Mol Biol; 2008 Sep; 381(4):928-40. PubMed ID: 18590740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The SOCS box-adapting proteins for ubiquitination and proteasomal degradation.
    Linossi EM; Nicholson SE
    IUBMB Life; 2012 Apr; 64(4):316-23. PubMed ID: 22362562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional cross-modulation between SOCS proteins can stimulate cytokine signaling.
    Piessevaux J; Lavens D; Montoye T; Wauman J; Catteeuw D; Vandekerckhove J; Belsham D; Peelman F; Tavernier J
    J Biol Chem; 2006 Nov; 281(44):32953-66. PubMed ID: 16956890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of the SOCS4-ElonginB/C complex reveals a distinct SOCS box interface and the molecular basis for SOCS-dependent EGFR degradation.
    Bullock AN; Rodriguez MC; Debreczeni JE; Songyang Z; Knapp S
    Structure; 2007 Nov; 15(11):1493-504. PubMed ID: 17997974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The many faces of the SOCS box.
    Piessevaux J; Lavens D; Peelman F; Tavernier J
    Cytokine Growth Factor Rev; 2008; 19(5-6):371-81. PubMed ID: 18948053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The E3 ubiquitin ligase HOIL-1 induces the polyubiquitination and degradation of SOCS6 associated proteins.
    Bayle J; Lopez S; Iwaï K; Dubreuil P; De Sepulveda P
    FEBS Lett; 2006 May; 580(11):2609-14. PubMed ID: 16643902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis of intersubunit recognition in elongin BC-cullin 5-SOCS box ubiquitin-protein ligase complexes.
    Kim YK; Kwak MJ; Ku B; Suh HY; Joo K; Lee J; Jung JU; Oh BH
    Acta Crystallogr D Biol Crystallogr; 2013 Aug; 69(Pt 8):1587-97. PubMed ID: 23897481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressors of cytokine signalling: SOCS.
    Larsen L; Röpke C
    APMIS; 2002 Dec; 110(12):833-44. PubMed ID: 12645661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The SOCS2 ubiquitin ligase complex regulates growth hormone receptor levels.
    Vesterlund M; Zadjali F; Persson T; Nielsen ML; Kessler BM; Norstedt G; Flores-Morales A
    PLoS One; 2011; 6(9):e25358. PubMed ID: 21980433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2.
    Rui L; Yuan M; Frantz D; Shoelson S; White MF
    J Biol Chem; 2002 Nov; 277(44):42394-8. PubMed ID: 12228220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A three-dimensional model of Suppressor Of Cytokine Signalling 1 (SOCS-1).
    Giordanetto F; Kroemer RT
    Protein Eng; 2003 Feb; 16(2):115-24. PubMed ID: 12676980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BC-box protein domain-related mechanism for VHL protein degradation.
    Pozzebon ME; Varadaraj A; Mattoscio D; Jaffray EG; Miccolo C; Galimberti V; Tommasino M; Hay RT; Chiocca S
    Proc Natl Acad Sci U S A; 2013 Nov; 110(45):18168-73. PubMed ID: 24145437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosine phosphorylation disrupts elongin interaction and accelerates SOCS3 degradation.
    Haan S; Ferguson P; Sommer U; Hiremath M; McVicar DW; Heinrich PC; Johnston JA; Cacalano NA
    J Biol Chem; 2003 Aug; 278(34):31972-9. PubMed ID: 12783885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct activities of suppressor of cytokine signaling (SOCS) proteins and involvement of the SOCS box in controlling G-CSF signaling.
    van de Geijn GJ; Gits J; Touw IP
    J Leukoc Biol; 2004 Jul; 76(1):237-44. PubMed ID: 15107455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinase inhibition, competitive binding and proteasomal degradation: resolving the molecular function of the suppressor of cytokine signaling (SOCS) proteins.
    Linossi EM; Nicholson SE
    Immunol Rev; 2015 Jul; 266(1):123-33. PubMed ID: 26085211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The SOCS box encodes a hierarchy of affinities for Cullin5: implications for ubiquitin ligase formation and cytokine signalling suppression.
    Babon JJ; Sabo JK; Zhang JG; Nicola NA; Norton RS
    J Mol Biol; 2009 Mar; 387(1):162-74. PubMed ID: 19385048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.